May 02, 2016 - Talcum Powder Long Term Exposure Ovarian Cancer Risk - Many women in the United States have heard about the recent studies linking the use of talcum powder in the genital region to ovarian cancer. Currently there are more than 1,200 lawsuits filed against Johnson & Johnson by women who believe their ovarian cancer diagnosis is related to the use of...

The Stryker Rejuvenate/ABGII Hip Recalls and Subsequent Lawsuits

In July, 2012, Stryker Corporation issued a recall for the Rejuvenate and ABGII hip implants. These devices had been on the market barely more than two years at the time of the recall. When Stryker marketed the implants, they claimed the devices would be perfect for the younger, more active patient. The design of the two Stryker implants was extremely unique, in that there were a variety of stem and neck pieces in different lengths and angles, allowing surgeons to custom-fit the device to the patient according to body size, gender and level of activity. The design also implemented a ceramic, rather than a metal ball, which Stryker claimed made it much safer than other metal-on-metal hip implants, and less likely to shed cobalt and chromium metal ion debris due to Stryker Rejuvenate/ABGII fretting and corrosion. 

The Status of the Stryker Rejuvenate/ABGII Hip Lawsuits

If your are the recipient of a Stryker Rejuvenate/ABGII hip implant, you likely heard of the Stryker Rejuvenate/ABGII hip recalls in July, 2012. Despite the fact that Stryker had marketed both devices as being safer than other metal-on-metal hip implants (due to the use of a ceramic ball) and much longer lasting that most all other hip implants, these claims turned out to be less than accurate. Shortly after the two devices were released in early 2010, adverse event reports began coming in to the FDA. These adverse event reports came from consumers and surgeons alike. In fact, several surgeons notified the FDA that they noted a substance which looked like “black rust” on Stryker Rejuvenate/ABGII hip implants removed from their patients.